A drug utilisation study in patients treated with EXELON®/PROMETAX® (rivastigmine) transdermal patch

24/09/2014
02/07/2024
EU PAS number:
EUPAS7537
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

cena713d2409-redacted protocol

English (756.01 KB - PDF) View document
Updated protocol

ena713d2409-v02--protocol amendment redacted

First published: 22/02/2024
English (1.06 MB - PDF) View document
Study results
Study results

ena713d2409--legacy-clinical-study-report_Redacted2

English (6.45 MB - PDF) View document
Study report
Other information